Division of Minimally Invasive Surgery, Department of Surgery, University of California San Diego, 9300 Campus Point Dr La Jolla, San Diego, CA, 92037, USA.
Surg Endosc. 2024 Nov;38(11):6294-6304. doi: 10.1007/s00464-024-11192-0. Epub 2024 Aug 23.
Robotic-assisted metabolic and bariatric surgery (MBS) is gaining popularity. Revisional MBS is associated with higher perioperative morbidity compared to primary MBS. The optimal surgical approach to minimize complications in these complex cases is unclear. The goal of this study was to assess robot utilization in revisional MBS and compare laparoscopic and robotic revisional MBS outcomes in the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) database.
A retrospective review of the MBSAQIP database was performed identifying revisional sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) cases from 2015 to 2022. Primary MBS, open/emergent cases, cases converted to another approach, and combined cases other than esophagogastroduodenoscopy were excluded. 30-Day outcomes for laparoscopic and robotic cases were compared using multivariate logistic regression adjusting for patient demographics, comorbidities, and operative variables.
41,404 Cases (14,474 SG; 26,930 RYGB) were identified. From 2015 to 2022, the percentage of revisional SG and RYGB cases performed robotically increased from 6.1% and 7.3% to 24.2% and 32.0% respectively. Laparoscopic SG had similar rates of overall morbidity, leak, bleeding, readmission, reoperation, and length of stay compared to robotic. Laparoscopic RYGB had significantly higher rates of overall morbidity (6.2% vs. 4.8%, p < 0.001, AOR 0.80 [0.70-0.93]), blood transfusion (1.5% vs. 1.0%, p < 0.05, AOR 0.74 [0.55-0.99]), superficial incisional SSI (1.2% vs. 0.4%, p < 0.001, AOR 0.30 [0.19-0.47]), and longer length of stay (1.87 vs. 1.76 days, p < 0.001) compared to robotic. Laparoscopic operative times were significantly shorter than robotic (SG: 86.4 ± 45.8 vs. 113.5 ± 51.7 min; RYGB: 130.7 ± 64.7 vs. 165.5 ± 66.8 min, p < 0.001).
Robot utilization in revisional bariatric surgery is increasing. Robotic surgery has lower postoperative morbidity and shorter length of stay in revisional RYGB when compared to laparoscopic. Robotic platforms may have the capacity to improve the delivery of care for patients undergoing revisional bariatric surgery.
机器人辅助代谢和减重手术(MBS)越来越受欢迎。与原发性 MBS 相比, revisions MBS 与更高的围手术期发病率相关。在这些复杂病例中,以最小化并发症为目标的最佳手术方法尚不清楚。本研究的目的是评估机器人在 revisions MBS 中的应用,并比较腹腔镜和机器人 revisions MBS 在代谢和减重手术认证和质量改进计划(MBSAQIP)数据库中的结果。
对 MBSAQIP 数据库进行回顾性分析,确定 2015 年至 2022 年期间的 revisions 袖状胃切除术(SG)和 Roux-en-Y 胃旁路术(RYGB)病例。排除原发性 MBS、开放性/紧急性病例、转换为其他方法的病例以及其他除食管胃十二指肠镜检查以外的联合病例。使用多元逻辑回归比较腹腔镜和机器人病例的 30 天结果,调整患者人口统计学、合并症和手术变量。
共确定 41404 例病例(14474 例 SG;26930 例 RYGB)。2015 年至 2022 年,机器人辅助 revisions SG 和 RYGB 病例的比例从 6.1%和 7.3%分别增加到 24.2%和 32.0%。与机器人相比,腹腔镜 SG 的总体发病率、漏诊、出血、再入院、再次手术和住院时间相似。腹腔镜 RYGB 的总体发病率(6.2%比 4.8%,p<0.001,AOR 0.80 [0.70-0.93])、输血(1.5%比 1.0%,p<0.05,AOR 0.74 [0.55-0.99])、浅表切口 SSI(1.2%比 0.4%,p<0.001,AOR 0.30 [0.19-0.47])和住院时间更长(1.87 比 1.76 天,p<0.001)明显更高。腹腔镜手术时间明显短于机器人(SG:86.4±45.8 比 113.5±51.7 分钟;RYGB:130.7±64.7 比 165.5±66.8 分钟,p<0.001)。
机器人在 revisions 减重手术中的应用正在增加。与腹腔镜相比,机器人手术在 revisions RYGB 中术后发病率较低,住院时间较短。机器人平台可能有能力改善接受 revisions 减重手术患者的治疗效果。